51 – 60 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Non-genomic effects of androgens on isolated human vascular and nonvascular penile erectile tissue
(
- Contribution to journal › Article
-
Mark
Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
(
- Contribution to journal › Article
-
Mark
Incontinent urinary diversion.
(
- Contribution to journal › Article
-
Mark
Management of advanced prostate cancer: can we improve on androgen deprivation therapy?
(
- Contribution to journal › Article
- 2007
-
Mark
The urologist's guide to low dose-rate interstitial brachytherapy with permanent seed implants for localized prostate cancer.
(
- Contribution to journal › Scientific review
-
Mark
What should a urologist know about hereditary predisposition to prostate cancer?
(
- Contribution to journal › Scientific review
-
Mark
Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1 alpha
(
- Contribution to journal › Article
-
Mark
Active surveillance vs radical prostatectomy.
(
- Contribution to journal › Article
-
Mark
Inhibition of the epidermal growth factor receptor in bladder cancer cells treated with the DNA-damaging drug etoposide markedly increases apoptosis
(
- Contribution to journal › Article
- 2006
-
Mark
Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.
(
- Contribution to journal › Article